Hazelden Betty Ford Reports Latest Treatment Results, Patient Outcomes
Helping People Outlive the Disease of AddictionCenter City, Minnesota--(Newsfile Corp. - July 23, 2024) - As the U.S. confronts a...
Mental Health
ViewMind Applauded by Frost & Sullivan for Revolutionizing Brain Health Assessment and Care with Its Ocular Digital Phenotyping Solution
ViewMind's Ocular Digital Phenotyping solution is a holistic approach to brain and mental health that builds trust through technology, enabling...
Optimi Health to Enter Asian Market with PsiloThai Collaboration on Psilocybin Research
Observational studies to focus on patients with addiction and end-of-life distress pending formal approval and permitting from Thai health authoritiesVancouver,...
Jaguar Health Reports Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer
Initial results of unprecedented trial including 10 different tumor types indicate that OnTarget did not meet its primary endpoint across...
BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024
BURLINGTON, Mass. and JERUSALEM, July 23, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
Reunion Neuroscience Inc. Announces First Patient Dosed in Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression
MORRISTOWN, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to pushing the boundaries...
Awakn Life Sciences Provides Update on Aminoindane New Chemical Entity Patent Portfolio
Toronto, Ontario--(Newsfile Corp. - July 22, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or...
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine’s Drug Resistance
New findings highlight potential advantages of MIRA's novel oral ketamine analog for treating neurological and neuropsychiatric disorders MIAMI, FL /...
Aetna Policy Update Expands TMS Availability for Adolescents With Depression
Coverage criteria consistent with recent FDA clearance for NeuroStar TMSMALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:...
60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study
The Tafenoquine for Babesiosis clinical trial will be conducted at three sites: Yale University, Rhode Island Hospital and Tufts Medical...
LifeStance to Host Second Quarter 2024 Earnings Conference Call on August 8, 2024
SCOTTSDALE, Ariz., July 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers...
Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning
Webcast on Tuesday, July 23rd at 8:30 AM Eastern will include updates on Jaguar's cancer supportive care portfolio, including participation...
Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery
‘Breaking Barriers’ Coalition Formed to Address Opioid Use Disorder in the USA Nexalin CEO Mark White Participates in Inaugural Meeting...
HealthyMD and IMG Health Clinic Unite to Advance Health Equity and Access to Care for 50M+ Underserved People Across the U.S.
Groundbreaking hybrid care model elevates standard of care for sexual healthcare of underserved populations, improves quality of life, and strengthens...
First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
Boehringer_Workplace_Lab_Research Media image Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncologyFurther data read-outs expected in 2024 in oncology,...
Awakn Life Sciences Announces Collaboration Agreement with Graft Polymer (UK) PLC
Toronto, Ontario--(Newsfile Corp. - July 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or...
BioWorld by Clarivate Celebrates Nine Wins at 2024 APEX Awards
Recognized for excellence in writing, news, mental health, financial/investment and economics categories LONDON, July 18, 2024 /PRNewswire/ -- BioWorld™ published...
Medicat Integrates with CCMH to Improve College Student Mental Health
ATLANTA, July 17, 2024 /PRNewswire/ -- Medicat, the leading provider of Electronic Health Records (EHR) software for college health and counseling...
WELL Health Launches its AI-POWERED Co-pilot for Cardiologists powered by HEALWELL AI to Help Improve Detection of Cardiovascular Disease
WELL has launched its new AI-powered physician co-pilot to assist cardiologists in better identifying patients at high risk of cardiovascular...
New Independent Actuarial Study Shows Personify Health Lowers Healthcare Spend by 23%
Wakely Consulting Group analysis also finds that high-cost claimant members utilizing Personify Health's comprehensive benefits platform have 14% lower costs...